Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection
Clinical trial NCT04349098 · COMPLETED
Trial details
- NCT number
- NCT04349098
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-17
- Primary completion
- 2020-10-05
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.